The facilities were inaugurated by Tirumala Tirupati Devasthanams (TTD) chairman B.R. Naidu under the Sri Balaji ...

What began as a routine stage 1 breast cancer diagnosis in late 2023 at the age of 53 was radically redefined not by ...

CINDERELLA clinical trial: Using artificial intelligence–driven healthcare to enhance breast cancer locoregional treatment decisions. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting ...

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, ...

BeSound refreshes the breast cancer screening experience with a radiation-free ultrasound and a 24-to-48-hour turnaround time ...

Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy ...

QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging ...

Chinese scientists have applied artificial intelligence to help doctors more precisely separate tumors from surrounding healthy tissue — a process they liken to removing pits from fruits — improving ...

Recurrent breast cancer remains a major clinical challenge, accounting for the majority of breast cancer–related mortality despite significant advances in ...

Radiation is an immunomodulator that can either stimulate or suppress the immune response against cancer. The spectrum of potentially immunostimulatory ...

Boron neutron capture therapy is being used in Japan to target and treat head and neck tumours. Many other countries are now building facilities. In 2020, Japan became the first country to approve ...